Finerenone Oral Tablet

DRUG4 trials

Sponsors

University of North Carolina, Chapel Hill, Qifu Li, Steno Diabetes Center Copenhagen, Juntendo University

Conditions

Acute Heart FailureAlbuminuriaKidney Transplant; ComplicationsPrimary AldosteronismType 2 DMType 2 DM /Diabetic Nephropathy

Phase 2

The EFfect of FinErenone in Kidney TransplantiOn Recipients: The EFFEKTOR Study

RecruitingNCT06059664

University of North Carolina, Chapel HillKidney Transplant; Complications

Start: 2024-04-23End: 2027-09-30Target: 150Updated: 2025-05-25

Phase 4

Finerenone for Patients With Primary Aldosteronism (FAIRY)

RecruitingNCT06457074

Qifu LiPrimary Aldosteronism

Start: 2024-06-04End: 2026-06-01Target: 306Updated: 2024-08-30

Urinary Proteomics to Guide Early Intervention to Prevent Complications in Type 2 Diabetes - a Feasibility Study

Enrolling by invitationNCT06954090

Steno Diabetes Center CopenhagenAlbuminuria, Type 2 DM, Type 2 DM /Diabetic Nephropathy

Start: 2025-11-20End: 2027-05-31Target: 50Updated: 2025-12-22

Efficacy and Safety With Early Treatment of Finerenone in Hospitalized Patients With Heart Failure

RecruitingNCT07397650

Juntendo UniversityAcute Heart Failure

Start: 2026-02-01End: 2028-09-30Target: 550Updated: 2026-02-11